Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
Clinical trial NCT04739670 · UNKNOWN
Trial details
- NCT number
- NCT04739670
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2025-09-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.